Khan Yusra Habib, Sarriff Azmi, Adnan Azreen Syazril, Khan Amer Hayat, Mallhi Tauqeer Hussain
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, University Sains Malaysia, Penang, 11800, Malaysia.
Chronic Kidney Disease Resource Centre, School of Medical Sciences, Health Campus, University Sains Malaysia, Kubang Kerain, 16150, Kelantan, Malaysia.
PLoS One. 2016 Jul 21;11(7):e0159335. doi: 10.1371/journal.pone.0159335. eCollection 2016.
Despite promising role of diuretics to manage fluid overload among chronic kidney disease (CKD) patients, their use is associated with adverse renal outcomes. Current study aimed to determine the extent of renal deterioration with diuretic therapy.
A total 312 non-dialysis dependent CKD (NDD-CKD) patients were prospectively followed-up for one year. Fluid overload was assessed via bioimpedance spectroscopy. Estimated GFR (eGFR) was calculated from serum creatinine values by using Chronic Kidney Disease- Epidemiology Collaboration (CKD-EPI) equation.
Out of 312 patients, 64 (20.5%) were hypovolemic while euvolemia and hypervolemia were observed in 113 (36.1%) and 135 (43.4%) patients. Overall 144 patients were using diuretics among which 98 (72.6%) were hypervolemic, 35 (30.9%) euvolemic and 11 (17.2%) were hypovolemic. The mean decline in estimated GFR of entire cohort was -2.5 ± 1.4 ml/min/1.73m2 at the end of follow up. The use of diuretics was significantly associated with decline in eGFR. A total of 36 (11.5%) patients initiated renal replacement therapy (RRT) and need of RRT was more profound among diuretic users.
The use of diuretics was associated with adverse renal outcomes indicated by decline in eGFR and increasing risk of RRT initiation in our cohort of NDD-CKD patients. Therefore, it is cautiously suggested to carefully prescribe diuretics by keeping in view benefit versus harm for each patient.
尽管利尿剂在慢性肾脏病(CKD)患者管理液体超负荷方面具有潜在作用,但其使用与不良肾脏结局相关。本研究旨在确定利尿剂治疗导致肾脏恶化的程度。
对312例非透析依赖的CKD(NDD-CKD)患者进行了为期一年的前瞻性随访。通过生物电阻抗光谱法评估液体超负荷情况。使用慢性肾脏病流行病学协作组(CKD-EPI)方程根据血清肌酐值计算估算肾小球滤过率(eGFR)。
在312例患者中,64例(20.5%)为血容量不足,113例(36.1%)为血容量正常,135例(43.4%)为血容量过多。共有144例患者使用利尿剂,其中98例(72.6%)血容量过多,35例(30.9%)血容量正常,11例(17.2%)血容量不足。随访结束时,整个队列的估算GFR平均下降-2.5±1.4 ml/min/1.73m²。利尿剂的使用与eGFR下降显著相关。共有36例(11.5%)患者开始肾脏替代治疗(RRT),利尿剂使用者中RRT的需求更为迫切。
在我们的NDD-CKD患者队列中,利尿剂的使用与不良肾脏结局相关,表现为eGFR下降和开始RRT的风险增加。因此,谨慎建议在考虑每位患者的利弊后谨慎开具利尿剂处方。